Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1α: Implications for metabolic disease

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 5, 2007, Pages 874-883

  Muoio, Deborah M ^a,b   Koves, Timothy R ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Energy metabolism; Exercise; Fatty acids; Insulin resistance; Mitochondria; Nuclear receptors; Obesity; Skeletal muscle

Indexed keywords

FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL; HUMAN; METABOLISM; REVIEW; SKELETAL MUSCLE;

ANIMALS; FATTY ACIDS; HUMANS; MUSCLE, SKELETAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TRANSCRIPTION FACTORS;

EID: 36148937475     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-083     Document Type: Review

References (73)

1. Abu-Elheiga, L., Matzuk, M.M., Abo-Hashema, K.A., and Wakil, S.J. 2001. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science (Washinton, D.C.), 291: 2613-2616. doi:10.1126/science.1056843. PMID:11283375.
2. Adhihetty, P.J., Irrcher, I., Joseph, A.M., Ljubicic, V., and Hood, D.A. 2003. Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp. Physiol. 88: 99-107. doi:10.1113/eph8802505. PMID:12525859.
3. Ames, B.N., and Liu, J. 2004. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann. N. Y. Acad. Sci. 1033: 108-116. doi:10.1196/annals.1320.010. PMID:15591008.
4. An, J., Muoio, D.M., Shiota, M., Fujimoto, Y., Cline, G.W., Shulman, G.I., et al. 2004. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10: 268-274. doi:10.1038/nm995. PMID:14770177.
5. Anderson, E.J., and Neufer, P.D. 2006. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am. J. Physiol. Cell Physiol. 290: C844-C851. PMID:16251473.
6. Andreyev, A.Y., Kushnareva, Y.E., and Starkov, A.A. 2005. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.), 70: 200-214. PMID:15807660.
7. Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., et al. 2005. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11: 191-198. doi:10.1038/nm1185. PMID:15685170.
8. Astrup, A. 2001. Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity. Public Health Nutr. 4: 499-515. PMID:11683545.
9. Bloch-Damti, A., and Bashan, N. 2005. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox Signal. 7: 1553-1567. doi:10.1089/ars.2005.7.1553. PMID:16356119.
10. Brookes, P.S. 2005. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic. Biol. Med. 38: 12-23. doi:10.1016/j.freeradbiomed. 2004.10.016. PMID:15589367.
11. Brookes, P.S., Yoon, Y., Robotham, J.L., Anders, M.W., and Sheu, S.S. 2004. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287: C817-C833. doi:10.1152/ajpcell.00139.2004. PMID:15355853.
12. Bruce, C.R., Anderson, M.J., Carey, A.L., Newman, D.G., Bonen, A., Kriketos, A.D., et al. 2003. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 88: 5444-5451. doi:10.1210/jc.2003-030791. PMID:14602787.
13. Bruce, C.R., Kriketos, A.D., Cooney, G.J., and Hawley, J.A. 2004. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia, 47: 23-30. doi:10.1007/s00125-003-1265-7. PMID:14673522.
14. Chakraborti, S., and Chakraborti, T. 1998. Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: a brief overview. Cell. Signal. 10: 675-683. doi:10.1016/S0898-6568(98)00014-X. PMID:9884018.
15. Deems, R.O., Anderson, R.C., and Foley, J.E. 1998. Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys. Am. J. Physiol. 274: R524-R528. PMID:9486313.
16. Deschamps, D., Fisch, C., Fromenty, B., Berson, A., Degott, C., and Pessayre, D. 1991. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. J. Pharmacol. Exp. Ther. 259: 894-904. PMID:1941634.
17. Finck, B.N., Lehman, J.J., Leone, T.C., Welch, M.J., Bennett, M.J., Kovacs, A., et al. 2002. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109: 121-130. doi:10.1172/JCI200214080. PMID:11781357.
18. Gaillard, S., Grasfeder, L.L., Haeffele, C.L., Lobenhofer, E.K., Chu, T.M., Wolfinger, R., et al. 2006. Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Mol. Cell, 24: 797-803. doi:10.1016/j.molcel.2006. 10.012. PMID:17157261.
19. Giannessi, F., Pessotto, P., Tassoni, E., Chiodi, P., Conti, R., De Angelis, F., et al. 2003. Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity. J. Med. Chem. 46: 303-309. doi:10.1021/jm020979u. PMID: 12519067.
20. Gilde, A.J., and Van Bilsen, M. 2003. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol. Scand. 178: 425-434. doi:10.1046/j.1365-201X.2003.01161.x. PMID:12864748.
21. Goodpaster, B.H., and Kelley, D.E. 1998. Role of muscle in triglyceride metabolism. Curr. Opin. Lipidol. 9: 231-236. PMID: 9645506.
22. Goodpaster, B.H., and Kelley, D.E. 2002. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr. Diab. Rep. 2: 216-222. doi:10.1007/s11892-002-0086-2. PMID:12643176.
23. Goodpaster, B.H., He, J., Watkins, S., and Kelley, D.E. 2001. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 86: 5755-5761. doi:10.1210/jc.86.12.5755. PMID:11739435.
24. Griffin, M.E., Marcucci, M.J., Cline, G.W., Bell, K., Barucci, N., Lee, D., et al. 1999. Free fatty acid induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes, 48: 1270-1274. doi:10.2337/diabetes.48.6.1270. PMID:10342815.
25. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T., Maeda, K., et al. 2002. A central role for JNK in obesity and insulin resistance. Nature (London), 420: 333-336. doi:10.1038/nature01137. PMID:12447443.
26. Hulver, M.W., Berggren, J.R., Cortright, R.N., Dudek, R.W., Thompson, R.P., Pories, W.J., et al. 2003. Skeletal muscle lipid metabolism with obesity. Am. J. Physiol. Endocrinol. Metab. 284: E741-E747. PMID:12626325.
27. Issemann, I., and Green, S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London), 347: 645-650. doi:10.1038/347645a0. PMID:2129546.
28. Kim, J.K., Kim, Y.J., Fillmore, J.J., Chen, Y., Moore, I., Lee, J., et al. 2001. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108: 437-446. doi:10.1172/JCI200111559. PMID:11489937.
29. Kim, J.K., Fillmore, J.J., Sunshine, M.J., Albrecht, B., Higashimori, T., Kim, D.W., et al. 2004. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114: 823-827. doi:10.1172/ JCI200422230. PMID:15372106.
30. Kim, S.C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., et al. 2006. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell, 23: 607-618. doi:10.1016/j.molcel.2006.06. 026. PMID:16916647.
31. Koves, T.R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., et al. 2005a. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 280: 33588-33598. doi:10.1074/jbc.M507621200. PMID:16079133.
32. Koves, T.R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., et al. 2005b. PPARgamma coactivator-lalpha -mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 280: 33588-33598. doi:10.1074/jbc.M507621200. PMID: 16079133.
33. Koves, T.R., Noland, R.C., Bates, A.L., Henes, ST., Muoio, D.M., and Cortright, R.N. 2005c. Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. Am. J. Physiol. Cell Physiol. 288: C1074-C1082. doi:10.1152/ajpcell.00391.2004. PMID:15647392.
34. Kumaran, S., Subathra, M., Balu, M., and Panneerselvam, C. 2004. Age-associated decreased activities of mitochondrial electron transport chain complexes in heart and skeletal muscle: role of L-carnitine. Chem. Biol. Interact. 148: 11-18. PMID:15223352.
35. Kumaran, S., Subathra, M., Balu, M., and Panneerselvam, C. 2005. Supplementation of L-carnitine improves mitochondrial enzymes in heart and skeletal muscle of aged rats. Exp. Aging Res. 31: 55-67. doi:10.1080/03610730590882846. PMID:15842073.
36. Leone, T.C., Weinheimer, C.J., and Kelly, D.P. 1999. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U.S.A. 96: 7473-7478. doi:10.1073/pnas.96.13.7473. PMID:10377439.
37. Leone, T.C., Lehman, J.J., Finck, B.N., Schaeffer, P.J., Wende, A.R., Boudina, S., et al. 2005. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3: e101. doi:10.1371/journal.pbio.0030101. PMID:15760270.
38. Lin, J., Puigserver, P., Donovan, J., Tarr, P., and Spiegelman, B.M. 2002. Peroxisome proliferator-activated receptor gamma coactivator 1 beta (PGC-1 beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 277: 1645-1648. doi:10.1074/jbc.C100631200. PMID:11733490.
39. Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St Pierre, J., Zhang, C.Y., et al. 2004. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-lalpha null mice. Cell, 119: 121-135. doi:10.1016/j.cell.2004.09.013. PMID:15454086.
40. Lin, J., Handschin, C., and Spiegelman, B.M. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1: 361-370. PMID:16054085.
41. Ling, C., Poulsen, P., Carlsson, E., Ridderstrale, M., Almgren, P., Wojtaszewski, J., et al. 2004. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 114: 1518-1526. doi:10.1172/JCI200421889. PMID:15546003.
42. Lowell, B.B., and Shulman, G.I. 2005. Mitochondrial dysfunction and type 2 diabetes. Science (Washinton, D.C.), 307: 384-387. doi:10.1126/science. 1104343. PMID:15662004.
43. McGarry, J.D. 2002. Banting Lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes, 51: 7-18. PMID:11756317.
44. McGarry, J.D., Mannaerts, G.P., and Foster, D.W. 1977. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest. 60: 265-270. PMID:874089.
45. Meirhaeghe, A., Crowley, V., Lenaghan, C., Lelliott, C., Green, K., Stewart, A., et al. 2003. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem. J. 373: 155-165. doi:10.1042/BJ20030200. PMID:12678921.
46. Michael, L.F., Wu, Z.D., Cheatham, R.B., Puigserver, P., Adelmant, G., Lehman, J.J., et al. 2001. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl. Acad. Sei. U.S.A. 98: 3820-3825. doi:10.1073/pnas. 061035098. PMID:11274399.
47. Mingrone, G. 2004. Carnitine in type 2 diabetes. Ann. N. Y. Acad. Sci. 1033: 99-107. doi:10.1196/annals.1320.009. PMID:15591007.
48. Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., et al. 2003. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34: 267-273. doi:10.1038/ng1180. PMID:12808457.
49. Mootha, V.K., Handschin, C., Arlow, D., Xie, X., St Pierre, J., Sihag, S., et al. 2004. Erralpha and Gabpa/b specify PGC-1 alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U.S.A. 101: 6570-6575. doi:10.1073/pnas.0401401101. PMID:15100410.
50. Muoio, D.M., and Newgard, C.B. 2006. Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. Annu. Rev. Biochem. 75:367-401.
51. Muoio, D.M., Dohm, G.L., Tapscott, E.B., and Coleman, R.A. 1999. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am. J. Physiol. 276: E913-E921. PMID:10329986.
52. Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., et al. 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice - evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277: 26089-26097. doi:10.1074/jbc.M203997200. PMID:12118038.
53. Patti, M.E., Butte, A.J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., et al. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 100: 8466-8471. doi:10.1073/pnas. 1032913100. PMID:12832613.
54. Perseghin, G., Petersen, K., and Shulman, G.I. 2003. Cellular mechanism of insulin resistance: potential links with inflammation. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl. 3): S6-S11. doi:10.1038/sj.ijo.0802491. PMID:14704736.
55. Power, R.A., Hulver, M.W., Zhang, J.Y., Dubois, J., Marchand, R.M., Ilkayeva, O.R., et al. 2007. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia, 50: 824-832. doi:10.1007/s00125-007- 0605-4. PMID:17310372.
56. Puigserver, P., Wu, Z.D., Park, C.W., Graves, R., Wright, M., and Spiegelman, B.M. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92: 829-839. doi:10.1016/S0092-8674(00) 81410-5. PMID:9529258.
57. Randle, P.J. 1998. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14: 263-283. doi:10.1002/(SICI)1099-0895(199812)14:4<263::AID- DMR233>3.0.CO;2-C. PMID:10095997.
58. Randle, P.J., Garland, P.B., Hales, C.N., and Newsholme, E.A. 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1: 785-789. PMID:13990765.
59. Reitman, M.L., and Gavrilova, O. 2000. A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. Int. J. Obes. Relat. Metab. Disord. 24 (Suppl. 4): S11-S14. PMID:11126232.
60. Saltiel, A.R., and Pessin, J.E. 2002. Insulin signaling pathways in time and space. Trends Cell Biol. 12: 65-71. doi:10.1016/S0962-8924(01)02207- 3. PMID:11849969.
61. Shoelson, S.E., Lee, J., and Yuan, M. 2003. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl. 3): S49-S52. doi:10.1038/sj.ijo.0802501. PMID:14704745.
62. Shulman, G.I. 2000. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106: 171-176. PMID:10903330.
63. Sparks, L.M., Xie, H., Koza, R.A., Mynatt, R., Hulver, M.W., Bray, G.A., et al. 2005. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes, 54: 1926-1933. doi:10.2337/diabetes.54.7.1926. PMID:15983191.
64. St Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., et al. 2006. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127: 397-408. PMID:17055439.
65. Thyfault, J.P., Cree, M.G., Zheng, D., Zwetsloot, J.J., Tapscott, E.B., Koves, T.R., et al. 2006. Contraction of insulin resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. Am. J. Physiol. Cell Physiol. 292: C729-C739. doi:10.1152/ajpcell.00311.2006. PMID:17050616.
66. Unger, R.H., and Orci, L. 2001. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 15: 312-321. doi:10.1096/fj.00-0590. PMID:11156947.
67. Vega, R.B., Huss, J.M., and Kelly, D.P. 2000. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20: 1868-1876. doi:10.1128/MCB.20.5. 1868-1876.2000. PMID:10669761.
68. Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 98: 115-124. doi:10.1016/S0092-8674(00)80611-X. PMID:10412986.
69. Yamada, K.A., Kanter, E.M., and Newatia, A. 2000. Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum. J. Cardiovasc. Pharmacol. 36: 14-21. doi:10.1097/00005344-200007000-00002. PMID:10892655.
70. Yechoor, V.K., Patti, M.E., Saccone, R., and Kahn, C.R. 2002. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 99: 10587-10592. doi:10.1073/pnas.142301999. PMID:12149437.
71. Yu, C., Chen, Y., Cline, G.W., Zhang, D., Zong, H., Wang, Y., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277: 50230-50236. doi:10.1074/jbc.M200958200. PMID:12006582.
72. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., et al. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (Washington, D.C.), 293: 1673-1677. doi:10.1126/science.1061620. PMID:11533494.
73. Zarain-Herzberg, A., and Rupp, H. 2002. Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target. Expert Opin. Investig. Drugs, 11: 345-356. PMID:11866664.